2023 annual financial data
Denali Therapeutics 2023 Operating cash flow margin
Direct answer
Operating cash flow margin was -108.31%.
Operating income was -196,699,000 USD and net income was -145,224,000 USD.
Operating cash flow was -357,991,000 USD.
Get free Denali Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 330,531,000 USD
- Operating income
- -196,699,000 USD
- Net income
- -145,224,000 USD
- Operating cash flow
- -357,991,000 USD